1. Home
  2. PTGX vs OUT Comparison

PTGX vs OUT Comparison

Compare PTGX & OUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • OUT
  • Stock Information
  • Founded
  • PTGX 2006
  • OUT 2013
  • Country
  • PTGX United States
  • OUT United States
  • Employees
  • PTGX N/A
  • OUT N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • OUT Real Estate Investment Trusts
  • Sector
  • PTGX Health Care
  • OUT Real Estate
  • Exchange
  • PTGX Nasdaq
  • OUT Nasdaq
  • Market Cap
  • PTGX 2.7B
  • OUT 2.9B
  • IPO Year
  • PTGX 2016
  • OUT N/A
  • Fundamental
  • Price
  • PTGX $37.94
  • OUT $18.89
  • Analyst Decision
  • PTGX Strong Buy
  • OUT Hold
  • Analyst Count
  • PTGX 8
  • OUT 6
  • Target Price
  • PTGX $54.63
  • OUT $19.00
  • AVG Volume (30 Days)
  • PTGX 638.0K
  • OUT 1.5M
  • Earning Date
  • PTGX 02-25-2025
  • OUT 02-19-2025
  • Dividend Yield
  • PTGX N/A
  • OUT 4.86%
  • EPS Growth
  • PTGX N/A
  • OUT N/A
  • EPS
  • PTGX 2.68
  • OUT 1.41
  • Revenue
  • PTGX $323,795,000.00
  • OUT $1,838,900,000.00
  • Revenue This Year
  • PTGX $441.08
  • OUT N/A
  • Revenue Next Year
  • PTGX N/A
  • OUT $1.95
  • P/E Ratio
  • PTGX $14.23
  • OUT $13.24
  • Revenue Growth
  • PTGX 125.73
  • OUT 1.37
  • 52 Week Low
  • PTGX $24.21
  • OUT $12.57
  • 52 Week High
  • PTGX $48.89
  • OUT $19.98
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 47.00
  • OUT 58.62
  • Support Level
  • PTGX $35.03
  • OUT $17.37
  • Resistance Level
  • PTGX $38.50
  • OUT $19.41
  • Average True Range (ATR)
  • PTGX 1.55
  • OUT 0.51
  • MACD
  • PTGX 0.15
  • OUT 0.15
  • Stochastic Oscillator
  • PTGX 63.65
  • OUT 81.68

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About OUT OUTFRONT Media Inc.

Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's major customers include entities within the retail, television, healthcare, and entertainment industries.

Share on Social Networks: